E Carmack Holmes - Net Worth and Insider Trading
E Carmack Holmes Net Worth
The estimated net worth of E Carmack Holmes is at least $9 dollars as of 2024-05-26. E Carmack Holmes is the Director of Plus Therapeutics Inc and owns about 4 shares of Plus Therapeutics Inc (PSTV) stock worth over $9. Details can be seen in E Carmack Holmes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that E Carmack Holmes has not made any transactions after 2011-08-19 and currently still holds the listed stock(s).
Transaction Summary of E Carmack Holmes
E Carmack Holmes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, E Carmack Holmes owns 1 companies in total, including Plus Therapeutics Inc (PSTV) .
Click here to see the complete history of E Carmack Holmes’s form 4 insider trades.
Insider Ownership Summary of E Carmack Holmes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2011-08-19 | director |
E Carmack Holmes Latest Holdings Summary
E Carmack Holmes currently owns a total of 1 stock. E Carmack Holmes owns 4 shares of Plus Therapeutics Inc (PSTV) as of August 19, 2011, with a value of $9.
Latest Holdings of E Carmack Holmes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PSTV | Plus Therapeutics Inc | 2011-08-19 | 4 | 2.14 | 9 |
Holding Weightings of E Carmack Holmes
E Carmack Holmes Form 4 Trading Tracker
According to the SEC Form 4 filings, E Carmack Holmes has made a total of 0 transactions in Plus Therapeutics Inc (PSTV) over the past 5 years. The most-recent trade in Plus Therapeutics Inc is the acquisition of 0 shares on August 19, 2011, which cost E Carmack Holmes around $9,450.
Insider Trading History of E Carmack Holmes
- 1
E Carmack Holmes Trading Performance
GuruFocus tracks the stock performance after each of E Carmack Holmes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by E Carmack Holmes is -7.57%. GuruFocus also compares E Carmack Holmes's trading performance to market benchmark return within the same time period. The performance of stocks bought by E Carmack Holmes within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how E Carmack Holmes's insider trading performs compared to the benchmark.
Performance of E Carmack Holmes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.94 | | | | | |
| Relative Return to S&P 500(%) | -0.23 | | | | | |
E Carmack Holmes Ownership Network
E Carmack Holmes Owned Company Details
What does Plus Therapeutics Inc do?
Who are the key executives at Plus Therapeutics Inc?
E Carmack Holmes is the director of Plus Therapeutics Inc. Other key executives at Plus Therapeutics Inc include President Marc H Hedrick , Chief Financial Officer Sims Andrew John Hugh Macintyre , and CHIEF MEDICAL OFFICER Norman D. Lafrance .
Plus Therapeutics Inc (PSTV) Insider Trades Summary
Over the past 18 months, E Carmack Holmes made no insider transaction in Plus Therapeutics Inc (PSTV). Other recent insider transactions involving Plus Therapeutics Inc (PSTV) include a net purchase of 27,261 shares made by Robert P Lenk , a net purchase of 20,297 shares made by Howard Clowes , and a net purchase of 32,255 shares made by Greg Petersen .
In summary, during the past 3 months, insiders sold 0 shares of Plus Therapeutics Inc (PSTV) in total and bought 48,285 shares, with a net purchase of 48,285 shares. During the past 18 months, 3,568 shares of Plus Therapeutics Inc (PSTV) were sold and 103,372 shares were bought by its insiders, resulting in a net purchase of 99,804 shares.
Plus Therapeutics Inc (PSTV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Plus Therapeutics Inc Insider Transactions
E Carmack Holmes Mailing Address
Above is the net worth, insider trading, and ownership report for E Carmack Holmes. You might contact E Carmack Holmes via mailing address: Ucla Dept Of Surgery, 10835 Lecente Ave, Los Angeles Ca 90095.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
